Abbott Q4 Results: Net profit rises 24% to Rs 287 crore, revenue up 7%
Abbott Q4 Results: Net profit rises 24% to Rs 287 crore, revenue up 7%
Drug maker Abbott India Ltd has reported a 24 percent year-on-year (YoY) growth in net profit at Rs 287 crore for the fourth quarter of the financial year 2023-24.
The company’s revenue increased 7 percent to Rs 1,439 crore from Rs 1,343 crore in the year-ago period, Abbott India said on May 9.
The company’s board recommended payment of final dividend of Rs 410 per equity share of Rs 10 each for the year ended March 31, 2024, subject to approval of the shareholders.
Shares of Abbott India closed 1.31 percent lower at Rs 25,606.55 apiece on BSE.
Abbott India, a subsidiary of Abbott Laboratories, has positioned itself as a market leader in pharmaceuticals, nutrition, devices and diagnostics. It offers over 400 brands, nutritional products for infants, children, adults and people with special dietary needs along with medical devices and diagnostics solutions.